Preliminary Program

DAY 1 - Friday, June 23rd
Arrival-Registration
Welcome Introduction
What is New and Interesting in Vascular Access
Moderators:
The Nephrologist’s view
The Vascular Surgeon’s view
The Interventional Radiologist’s View
Unmet Needs
Discussion
Panel:
Trial Updates
Moderators:
Studies TBA
Discussion
Company Symposium
Coffee Break
The Patient in Kidney Replacement Therapy
Moderators:
Frailty and its Impact on the Dialysis Patient
The Vascular Access Patient’s View
The Peritoneal Dialysis Patient’s View
The Transplanted Patient’s View
Discussion
Panel:
Home Dialysis
Moderators:
Hemo- and Peritoneal Home Dialysis. Global Overview and Financial Considerations
Home Dialysis is the Future
Home Dialysis Will Never be Established
Discussion
Panel:
Company Symposium
Percutaneous AVF Creation
Moderators:
Current Trends and What we Have Learned so Far
Things I have learned from my Thermal-based AVF Creation Cases
Things I have learned from my RF-based AVF Creation Cases

Secondary Interventions Case Sharing in Thermal-based AVFs
Secondary Interventions Case Sharing in RF-based AVFs
I Would Still Prefer a Gracz Fistula
Discussion
Panel:
Collaboration @ EVA
Lunch Break
Amazing Interventions Competition
Moderators:
Case 1
Case 2
Case 3
Case 4
Case 5
Discussion
Panel:
The Cardiovascular Implications of Vascular Access
Moderators:
The Effects of Dialysis in Blood Pressure
The Clinical Impact to the Heart
Hand Ischemia
Discussion
Panel:
Company Symposium
Central Venous Stenosis
Moderators:
Histopathologic and Hemodynamic Background of Central Venous Disease
Catheter-Related Central Venous Implications
Treatment Options in the Spotlight
Unmasking the Central Venous Stenosis
Don’t Treat it!
Discussion
Panel:
Collaboration @ EVA
Editor Writing Club
DAY 2 - Saturday, June 24th
Morbidity & Mortality Cases in Vascular Access
Moderators:
Case 1
Case 2
Case 3
Case 4
Discussion
Panel:
The Way Ahead
Moderators:
Titles TBA
Discussion
Panel:
Company Symposium
Collaboration @ EVA
Coffee Break
Declotting Devices: Available Options
Moderators:
Established Debulking Devices
Devices Used in Other Situations That Could Provide a Solution
Thrombolytic Agents. Are They Really Needed?
Antiplatelets and Anticoagulants During and After Thrombectomy. Do they play a role?
Discussion
Panel:
Company Symposium
Before “First-in-Human”
Moderators:
Titles TBA
Discussion
Panel:
Lunch Break
Guidelines Updates on Vascular Access Treatment
Moderators:
Titles TBA
Discussion
Panel:
Ultrasound in Vascular Access
Moderators:
Surgical and Percutaneous AVF Screening
POCUS in Vascular Access
Volume Flow. Is This the Ultimate Tool?
Evaluating Stenotic Types
Ultrasound-Guided Angioplasty
Discussion
Panel:
Company Symposium
The Financial Reality of Vascular Access Management
Moderators:
Medical Device Regulation in the European Union
Financial Analysis for the Use of DCBs in Vascular Access
Cost-Analysis of Covered Stent Use in Vascular Access
Financial Considerations of Percutaneous AVF Creation
Discussion
Panel:
Peritoneal Dilaysis
Moderators:
The Surgical Option
The Percutaneous Option
Periprocedural Complications & Treatment
Long-Term Complications & Treatment
Panel:
Editor Writing Club by Ziv Haskal (USA)